Clinical Trial Update: Safety and Effectiveness Study of the Solysafe Septal Occluder in Patients With Atrial Septum Defect and Patent Foramen Ovale [NA]

View source ↗

Summary

This clinical trial update reports on the safety and effectiveness of the Solysafe Septal Occluder for atrial septal defect and patent foramen ovale; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Septal Defect
• Patent Foramen Ovale

Drugs mentioned

• Solysafe Septal Occluder

Snippet

Sponsor: Carag AG | Conditions: Atrial Septal Defect, Patent Foramen Ovale | NA | Status: COMPLETED